Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Hamilton Thorne Ltd. (T:HTL)

Business Focus: Advanced Medical Equipment & Technology (NEC)

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
Company Contact
Address: 100 Cummings Ctr Ste 465e
BEVERLY MA 01915-6143
Tel: N/A
Website: https://www.hamiltonthorne.com
IR: See website
Key People
David Wolf
Executive Chairman of the Board
Ekaterina Torchilin
President, Chief Executive Officer, Director
Francesco Fragasso
Chief Financial Officer
Brett Fulton
Senior Vice President, General Manager of the HT Inc
   
Business Overview
Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.
Financial Overview
For the nine months ended 30 September 2023, Hamilton Thorne Ltd revenues increased 17% to $48.8M. Net loss totaled $1.1M vs. income of $930K. Revenues reflect Services & consumables segment increase of 23% to $28.2M, Equipement sales segment increase of 10% to $20.6M. Net loss reflects General and administrative increase of 54% to $11.5M (expense), Sales and marketing increase of 21% to $10.8M (expense).
Reporting Currency: U.S. Dollars
Enterprise value: $200.80M as of Sep 30, 2023
Annual revenue (TTM): $88.21M as of Sep 30, 2023
EBITDA (TTM): $8.70M as of Sep 30, 2023
Net annual income (TTM): -$0.23M as of Sep 30, 2023
Free cash flow (TTM): -$1.27M as of Sep 30, 2023
Net Debt Last Fiscal Year: $9.20M as of Sep 30, 2023
Shares outstanding: 151,823,695 as of Oct 12, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization